Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PNPLA3 encodes a multifunctional enzyme involved in triacylglycerol hydrolysis and lipid remodeling within cells, particularly in the liver and fat tissue. The I148M variant is strongly associated with increased risk for NAFLD and progression to more severe liver diseases. Expression is regulated by nutritional status.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Patatin-like Phospholipase Domain-Containing Protein 3 (PNPLA3).